🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 299734202 (prev. 299734103 )
- Market Cap
- Mid Cap
- IPO
- 5/9/2018 · $16.00/share
Business: Evelo Biosciences, Inc. is dedicated to improving the lives of patients globally through the development of a new modality of medicines monoclonal microbials. Evelo's monoclonal microbial product candidates are orally delivered and are intended to modulate systemic immunology and biology through direct interactions with human cells in the gut.
Company Contact
- CEO
- Simba Gill
- CFO
- Luca Scavo
- Headquarters
- 620 Memorial Drive, Suite 200, Cambridge, MA 02139
- Phone
- 617-577-0300
- Investor Relations
- Stefan Riley · 617-704-2333 · stefan@evelobio.com